To determine the cumulative incidence of acute upper gastrointestinal bleeding and its effect upon survival in patients with AIDS, 453 consecutive AIDS patients diagnosed in our hospital between June 1985 and March 1989 were foliowed for a median period of six months (maximum 42 months). The cumulative probability of acute gastrointestinal bleeding was 3% at six months and 6% at 14 months. This event was associated with significantly reduced survival. Independent risk factors for bleeding were: severe thrombocytopenia at the time of diagnosis and non-Hodgkin's lymphoma as the first clinical manifestation of AIDS. The potential causes of bleeding were investigated in all cases by emergency endoscopy or by necropsy examination in those patients whose clinical condition precluded the procedure. In nine of 15 patients, bleeding was due to lesions specifically associated with AIDS, but in the remainder the source of bleeding was not a direct consequence of HIV infection. We conclude that acute upper gastrointestinal bleeding rarely complicates the course of AIDS, but its occurrence is associated with decreased survival. As many of the causes are potentially treatable, a complete diagnostic approach is indicated in these patients, except those who are terminally ili.
The gastrointestinal tract represents a specific target organ in the acquired immunodeficiency syndrome (AIDS): best estimates indicate that from 50 to 90% of all AIDS patients develop digestive manifestations during the course of their disease,' 2 consisting mainly of infections by opportunistic organisms or malignant neoplasm."
Many of these abnormalities -for example infectious oesophagitis or gastroduodenal tumours -are potential sources of upper gastrointestinal haemorrhage. In addition, the risk of bleeding in AIDS patients may be further increased by severe thrombocytopenia, a condition that sometimes affects HIV infected individuals.78 In our experience, 8-9% of 608 drug addicts diagnosed to be HIV positive in 1985 presented with moderate to severe thrombocytopenia (platelet count <110 x 109/1 (unpublished data)).
Currently neither the incidence nor prevalence of acute gastrointestinal bleeding in AIDS patients is known, but it seems to be quite an uncommon manifestation. A number of clinical and necropsy studies have failed to describe a single case of acute upper gastrointestinal haemorrhage in more than 100 patients,29-1 but four cases of appreciable acute bleeding have recently been reported by Lane et al'2 in a series of 85 consecutive AIDS patients.
The purpose of the present study was twofold. Our first aim was to establish the cumulative incidence of acute upper gastrointestinal bleeding in a large series of patients with AIDS and the impact of this on the probability of survival.
Secondly, we wished to determine the spectrum of gastrointestinal lesions responsible for acute upper digestive haemorrhage in these patients. 7), and 6% at 14 months (95% CI 2 7-9 3) (Fig 1) . Acute upper gastrointestinal haemorrhage was significantly associated with the platelet count at the time of diagnosis. The frequency of bleeding increased progressively with the decrease in the number of platelets at diagnosis -at 15 months it was 2@1% in patients with mild thrombocytopenia or whose platelet count fell within the normal range, 5 8% in those with moderate thrombocytopenia, and 11 1% in patients with severe thrombocytopenia (p=005, Table II ). Conversely, there was no association between the absolute number of T4 lymphocytes at baseline, age, sex, or any of the particular risk factors for AIDS and acute bleeding.
Among the first clinical manifestations diagnostic of AIDS considered, only nonHodgkin's lymphoma was found to correlate with a significantly higher risk of acute haemorrhage (p<0025). In these patients, 13-5% had gastrointestinal bleeding during follow up compared with only 2-4% of those without nonHodgkin's lymphoma (odds ratio 5 6, 95% CI 1-8-17-7). Non-Hodgkin's lymphoma also remained a strong risk factor for bleeding after adjustment for the platelet count at baseline (Table III) . Haemorrhage was associated with a significantly reduced patient survival. Estimated survival rates at 12 months were 8% in bleeding patients v 64% in those who had not bled (p<0-001); in the latter group, estimated survival was as high as 24% at 27 months (Fig 2) . The relative risk of death in bleeding patients was 5-8 times (95% CI 3-4-10-3) that of the risk in patients who had had no episodes of bleeding. haemorrhage is an uncommon manifestation of AIDS, but its occurrence is associated with appreciably decreased patient survival. In the small subset of patients presenting with acute haemorrhage, median survival was only 62 days, in contrast with the large number of patients who never bled and whose clinical course was notably better, with a median survival of 549 days. Different factors may be responsible for this reduced survival. Firstly, bleeding may be linked directly to mortality. In six patients, death was an unequivocal consequence of massive haemorrhage; however, five of them were severely ill, which may have precluded their recovery from an event that they might have survived earlier in the course of the illness. Secondly, bleeding may reflect a more severe disease associated with a higher morbidity and mortality -for example AIDS related nonHodgkin's lymphoma.24 In this respect, it is noteworthy that one third of the cases of acute bleeding were observed in patients whose presenting feature of AIDS was an extranodal nonHodgkin's lymphoma. Among all the variables considered, other than the aforementioned first clinical manifestation of AIDS, only severe thrombocytopenia was an independent risk factor for bleeding. This may have important practical implications since it allows us to identify specific subgroups of patients with a higher risk of bleeding for whom a careful clinical and endoscopic surveillance is indicated.
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